Selenoprotein W enhances skeletal muscle differentiation by inhibiting TAZ binding to 14-3-3 protein

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 7, 2014, Pages 1356-1364

  Jeon, Yeong Ha ^a   Park, Yong Hwan ^a,b   Lee, Jea Hwang ^a   Hong, Jeong Ho ^a   Kim, Ick Young ^a  

^a Korea University   (South Korea)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

14 3 3; Selenoprotein W; TAZ

Indexed keywords

BINDING PROTEIN; MYOGENIN; OKADAIC ACID; PROTEIN 14 3 3; SELENOPROTEIN W; TAZ PROTEIN; UNCLASSIFIED DRUG; ENZYME INHIBITOR; MYOD PROTEIN; MYOD1 MYOGENIC DIFFERENTIATION PROTEIN; PROTEIN BINDING; SMALL INTERFERING RNA; TAZ PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS; CONTROLLED STUDY; DOWN REGULATION; MOUSE; MUSCLE CELL; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SKELETAL MUSCLE; ANIMAL; ANTAGONISTS AND INHIBITORS; BINDING SITE; CELL LINE; CYTOLOGY; CYTOSOL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

14-3-3 PROTEINS; ANIMALS; BINDING SITES; CELL DIFFERENTIATION; CELL LINE; CELL NUCLEUS; CYTOSOL; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEK293 CELLS; HUMANS; MICE; MUSCLE, SKELETAL; MYOBLASTS; MYOD PROTEIN; OKADAIC ACID; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN TRANSPORT; RNA, SMALL INTERFERING; SELENOPROTEIN W; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84899124098     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.04.002     Document Type: Article

References (48)

1. Driscoll D.M., Chavatte L. Finding needles in a haystack. In silico identification of eukaryotic selenoprotein genes. EMBO Rep. 2004, 5:140-141.
2. Lobanov A.V., Hatfield D.L., Gladyshev V.N. Eukaryotic selenoproteins and selenoproteomes. Biochim. Biophys. Acta 2009, 1790:1424-1428.
3. Kryukov G.V., Castellano S., Novoselov S.V., Lobanov A.V., Zehtab O., Guigo R., Gladyshev V.N. Characterization of mammalian selenoproteomes. Science 2003, 300:1439-1443.
4. Lu J., Holmgren A. Selenoproteins. J. Biol. Chem. 2009, 284:723-727.
5. Dikiy A., Novoselov S.V., Fomenko D.E., Sengupta A., Carlson B.A., Cerny R.L., Ginalski K., Grishin N.V., Hatfield D.L., Gladyshev V.N. SelT, SelW, SelH, and Rdx12: genomics and molecular insights into the functions of selenoproteins of a novel thioredoxin-like family. Biochemistry 2007, 46:6871-6882.
6. Vendeland S.C., Beilstein M.A., Chen C.L., Jensen O.N., Barofsky E., Whanger P.D. Purification and properties of selenoprotein W from rat muscle. J. Biol. Chem. 1993, 268:17103-17107.
7. Yeh J.Y., Beilstein M.A., Andrews J.S., Whanger P.D. Tissue distribution and influence of selenium status on levels of selenoprotein W. FASEB J. 1995, 9:392-396.
8. Jeong D.W., Kim E.H., Kim T.S., Chung Y.W., Kim H., Kim I.Y. Different distributions of selenoprotein W and thioredoxin during postnatal brain development and embryogenesis. Mol. Cells 2004, 17:156-159.
9. Loflin J., Lopez N., Whanger P.D., Kioussi C. Selenoprotein W during development and oxidative stress. J. Inorg. Biochem. 2006, 100:1679-1684.
10. Whanger P.D. Selenoprotein W: a review. Cell. Mol. Life Sci. 2000, 57:1846-1852.
11. Papp L.V., Lu J., Holmgren A., Khanna K.K. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid. Redox Signal. 2007, 9:775-806.
12. Noh O.J., Park Y.H., Chung Y.W., Kim I.Y. Transcriptional regulation of selenoprotein W by MyoD during early skeletal muscle differentiation. J. Biol. Chem. 2010, 285:40496-40507.
13. Park Y.H., Jeon Y.H., Kim I.Y. Selenoprotein W promotes cell cycle recovery from G2 arrest through the activation of CDC25B. Biochim. Biophys. Acta 2012, 1823:2217-2226.
14. Jeon Y.H., Park Y.H., Kwon J.H., Lee J.H., Kim I.Y. Inhibition of 14-3-3 binding to Rictor of mTORC2 for Akt phosphorylation at Ser473 is regulated by selenoprotein W. Biochim. Biophys. Acta 2013, 1833:2135-2142.
15. Aachmann F.L., Fomenko D.E., Soragni A., Gladyshev V.N., Dikiy A. Solution structure of selenoprotein W and NMR analysis of its interaction with 14-3-3 proteins. J. Biol. Chem. 2007, 282:37036-37044.
16. Musiani F., Ciurli S., Dikiy A. Interaction of selenoprotein W with 14-3-3 proteins: a computational approach. J. Proteome Res. 2011, 10:968-976.
17. Fu H., Subramanian R.R., Masters S.C. 14-3-3 proteins: structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol. 2000, 40:617-647.
18. Satoh J., Nanri Y., Yamamura T. Rapid identification of 14-3-3-binding proteins by protein microarray analysis. J. Neurosci. Methods 2006, 152:278-288.
19. Boston P.F., Jackson P., Thompson R.J. Human 14-3-3 protein: radioimmunoassay, tissue distribution, and cerebrospinal fluid levels in patients with neurological disorders. J. Neurochem. 1982, 38:1475-1482.
20. Celis J.E., Gesser B., Rasmussen H.H., Madsen P., Leffers H., Dejgaard K., Honore B., Olsen E., Ratz G., Lauridsen J.B., et al. Comprehensive two-dimensional gel protein databases offer a global approach to the analysis of human cells: the transformed amnion cells (AMA) master database and its link to genome DNA sequence data. Electrophoresis 1990, 11:989-1071.
21. Hunter T. Oncoprotein networks. Cell 1997, 88:333-346.
22. Forrest A., Gabrielli B. CDC25B activity is regulated by 14-3-3. Oncogene 2001, 20:4393-4401.
23. Yang H., Wen Y.Y., Zhao R., Lin Y.L., Fournier K., Yang H.Y., Qiu Y., Diaz J., Laronga C., Lee M.H. DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer. Cancer Res. 2006, 66:3096-3105.
24. Dibble C.C., Asara J.M., Manning B.D. Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1. Mol. Cell. Biol. 2009, 29:5657-5670.
25. Hong J.H., Hwang E.S., McManus M.T., Amsterdam A., Tian Y., Kalmukova R., Mueller E., Benjamin T., Spiegelman B.M., Sharp P.A., Hopkins N., Yaffe M.B. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 2005, 309:1074-1078.
26. Jeong H., Bae S., An S.Y., Byun M.R., Hwang J.H., Yaffe M.B., Hong J.H., Hwang E.S. TAZ as a novel enhancer of MyoD-mediated myogenic differentiation. FASEB J. 2010, 24:3310-3320.
27. Lei Q.Y., Zhang H., Zhao B., Zha Z.Y., Bai F., Pei X.H., Zhao S., Xiong Y., Guan K.L. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol. Cell. Biol. 2008, 28:2426-2436.
28. Zhao B., Li L., Lei Q., Guan K.L. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev. 2010, 24:862-874.
29. Liu C., Huang W., Lei Q. Regulation and function of the TAZ transcription co-activator. Int. J. Biochem. Mol. Biol. 2011, 2:247-256.
30. Kanai F., Marignani P.A., Sarbassova D., Yagi R., Hall R.A., Donowitz M., Hisaminato A., Fujiwara T., Ito Y., Cantley L.C., Yaffe M.B. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J. 2000, 19:6778-6791.
31. Mahoney W.M., Hong J.H., Yaffe M.B., Farrance I.K. The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. Biochem. J. 2005, 388:217-225.
32. Tournebize R., Andersen S.S., Verde F., Doree M., Karsenti E., Hyman A.A. Distinct roles of PP1 and PP2A-like phosphatases in control of microtubule dynamics during mitosis. EMBO J. 1997, 16:5537-5549.
33. Liu C.Y., Lv X., Li T., Xu Y., Zhou X., Zhao S., Xiong Y., Lei Q.Y., Guan K.L. PP1 cooperates with ASPP2 to dephosphorylate and activate TAZ. J. Biol. Chem. 2011, 286:5558-5566.
34. Kwon J.H., Lee J.H., Kim K.S., Chung Y.W., Kim I.Y. Regulation of cytosolic phospholipase A2 phosphorylation by proteolytic cleavage of annexin A1 in activated mast cells. J. Immunol. 2012, 188:5665-5673.
35. Cohen P. The structure and regulation of protein phosphatases. Annu. Rev. Biochem. 1989, 58:453-508.
36. Rudnicki M.A., Schnegelsberg P.N., Stead R.H., Braun T., Arnold H.H., Jaenisch R. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 1993, 75:1351-1359.
37. Davis R.L., Weintraub H., Lassar A.B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987, 51:987-1000.
38. Liu C.Y., Zha Z.Y., Zhou X., Zhang H., Huang W., Zhao D., Li T., Chan S.W., Lim C.J., Hong W., Zhao S., Xiong Y., Lei Q.Y., Guan K.L. The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase. J. Biol. Chem. 2010, 285:37159-37169.
39. Chang H.C., Rubin G.M. 14-3-3 epsilon positively regulates Ras-mediated signaling in Drosophila. Genes Dev. 1997, 11:1132-1139.
40. Zhang L., Wang H., Liu D., Liddington R., Fu H. Raf-1 kinase and exoenzyme S interact with 14-3-3zeta through a common site involving lysine 49. J. Biol. Chem. 1997, 272:13717-13724.
41. Rittinger K., Budman J., Xu J., Volinia S., Cantley L.C., Smerdon S.J., Gamblin S.J., Yaffe M.B. Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding. Mol. Cell 1999, 4:153-166.
42. Hennessy B.T., Smith D.L., Ram P.T., Lu Y., Mills G.B. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat. Rev. Drug Discov. 2005, 4:988-1004.
43. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
44. Basu S., Totty N.F., Irwin M.S., Sudol M., Downward J. Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol. Cell 2003, 11:11-23.
45. Hong J.H., Yaffe M.B. TAZ: a beta-catenin-like molecule that regulates mesenchymal stem cell differentiation. Cell Cycle 2006, 5:176-179.
46. Shenolikar S., Nairn A.C. Protein phosphatases: recent progress. Adv. Second Messenger Phosphoprotein Res. 1991, 23:1-121.
47. Yaffe M.B., Rittinger K., Volinia S., Caron P.R., Aitken A., Leffers H., Gamblin S.J., Smerdon S.J., Cantley L.C. The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 1997, 91:961-971.
48. Muslin A.J., Tanner J.W., Allen P.M., Shaw A.S. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 1996, 84:889-897.